Metronidazole for Treatment of <i>Clostridioides difficile</i> Infections in Brazil: A Single-Center Experience and Risk Factors for Mortality

Metronidazole for Treatment of <i>Clostridioides difficile</i> Infections in Brazil: A Single-Center Experience and Risk Factors for Mortality

We describe the epidemiology of <i>C. difficile</i> infections (CDIs) focused on treatment and analyze the risk factors for mortality. This is a retrospective cohort study of CDI cases with a positive A/B toxin in the stool in 2017–2018. We analyzed the demographic data, comorbidities, p...

Full description

Bibliographic Details
Main Authors: Joana Darc Freitas Alves, Augusto Yamaguti, João Silva de Mendonça, Cristiano de Melo Gamba, Cibele Lefreve Fonseca, Daniela K. S. Paraskevopoulos, Alexandre Inacio de Paula, Nair Hosino, Silvia Figueiredo Costa, Thaís Guimarães
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Antibiotics
Subjects:
<i>Clostridioides difficile</i>
metronidazole
mortality
Online Access:https://www.mdpi.com/2079-6382/11/9/1162

Internet

https://www.mdpi.com/2079-6382/11/9/1162

Similar Items